Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyowa Kirin
Pharma
Sanofi, DualityBio, UCB—Fierce Pharma Asia
Sanofi has suspended distribution of its flu vaccines in China. DualityBio filed for a Hong Kong IPO. UCB will offload some Chinese assets. And more.
Angus Liu
Aug 30, 2024 8:05am
Kyowa Kirin pulls outdated breast cancer drug from US market
Aug 26, 2024 9:35am
Merck, Leqembi, biosecurity—Fierce Pharma Asia
Aug 2, 2024 10:25am
Kyowa Kirin trims small molecule research, Asian operations
Aug 1, 2024 2:06pm
Grünenthal acquires Valinor Pharma and Movantik for $250M
Jul 22, 2024 11:12am
AbbVie-FutureGen, Takeda, Kyowa Kirin—Fierce Pharma Asia
Jun 14, 2024 5:00am
